Evidence map›Paper›PMID 21472765›Full record

ArticleJournal of neuroscience research2011

Expression of myelin genes: comparative analysis of Oli-neu and N20.1 oligodendroglial cell lines.

Glauber B Pereira, Anna Dobretsova, Hamdan Hamdan, Patricia A Wight

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of neuroscience research, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Glauber B PereiraDepartment of Physiology and Biophysics, University of Arkansas for Medical Sciences, Little Rock, Arkansas 72205, USA.
Anna Dobretsova
Hamdan Hamdan
Patricia A Wight
University of Arkansas for Medical Sciences · US

Funding

NEUROSCIENCE RESEARCH CENTER CORE FACILITY AT UAMSP30NS047546 · NINDS · UNIV OF ARKANSAS FOR MED SCIS · PI ZHANG, JUN-MING · 2004 to 2008
$3.1M
ANTISILENCING OF PLP GENE EXPRESSION IN OLIGODENDROCYTESR01NS037821 · NINDS · UNIV OF ARKANSAS FOR MED SCIS · PI WIGHT, PATRICIA A. · 1998 to 2010
$2.0M
NINDS NIH HHS P30 NS047546NINDS NIH HHS R01 NS037821
6 · The paper itself

Abstract

The use of immortalized cells has been instrumental as a tool with which to study gene regulation. However, it is crucial to understand the status of a given cell line, especially when investigating the regulation of genes whose expression is developmentally regulated. Several immortalized cell lines have been derived from primary cultures of mouse oligodendrocytes. Two such cell lines, N20.1 and Oli-neu, were characterized here in terms of their relative expression of myelin genes at both the mRNA level and the protein level. Analysis of the splice isoforms expressed by the myelin proteolipid protein (Plp1), myelin basic protein (Mbp), and 2',3'-cyclic nucleotide 3'-phosphodiesterase (Cnp) genes, along with the relative amount of protein expressed by these genes, suggests that the cell lines are representative of immature oligodendrocytes, although Oli-neu cells appear to be farther along the differentiation pathway compared with N20.1 cells. Previous studies have shown that the developmental increase in Plp1 gene expression that occurs during the active myelination period is governed by transcription regulatory elements present within the first intron. The responsiveness of one of these elements, the so-called antisilencer/enhancer (ASE), was investigated in both cell lines. Results presented here suggest that the ASE has a much more potent effect in Oli-neu cells. Thus, the two cell lines appear to be at different stages and will be useful as a means to study transcription regulatory elements whose influence changes during development.

Indexed as

2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseAnimalsCell DifferentiationCell LineageCell Line, TransformedEnhancer Elements, GeneticGene Expression Regulation, DevelopmentalGene Expression Regulation, EnzymologicMiceMyelin Basic ProteinMyelin Proteolipid ProteinOligodendrogliaPhosphoric Diester HydrolasesProtein Isoforms2',3'-Cyclic Nucleotide 3'-PhosphodiesteraseCnp protein, mouseMyelin Basic ProteinMyelin Proteolipid ProteinPhosphoric Diester HydrolasesPlp1 protein, mouseProtein Isoforms

Identifiers

PMID21472765
PMCPMC3088771
OpenAlexW2067695235

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.